Anest. intenziv. Med. 2026;37(1):50-53 | DOI: 10.36290/aim.2026.004

Monitoring of ionized magnesium and its importance for the critically illNew guidelines

Balík M.1, Duška F.2, Černý V.2-7, Šrámek V.8, Matějovič M.9, Springer D.10, Lahoda Brodská H.10
1 Klinika anesteziologie, resuscitace a intenzivní medicíny, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha
2 Klinika anesteziologie a resuscitace, Fakultní nemocnice Královské Vinohrady, 3. lékařská fakulta Univerzity Karlovy, Praha
3 Klinika anesteziologie, perioperační a intenzivní medicíny, Masarykova nemocnice v Ústí nad Labem, Univerzita J. E. Purkyně v Ústí nad Labem
4 Národní institut kvality a excelence zdravotnictví, Praha
5 Klinika anesteziologie, resuscitace a intenzivní medicíny, Lékařská fakulta v Hradci Králové, Univerzita Karlova v Praze
6 Department of Anesthesia, Pain Management and and Perioperative Medicine, Dalhousie University, Halifax, Canada
7 Ústav klinických oborů a biomedicíny, Technická univerzita Liberec
8 Klinika anesteziologie, resuscitace a intenzivní medicíny, Fakultní nemocnice U sv. Anny, Masarykova univerzita, Brno
9 I. interní klinika, Lékařská fakulta v Plzni, Univerzita Karlova a Fakultní nemocnice Plzeň
10 Ústav lékařské biochemie a laboratorní diagnostiky, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha

Ionised magnesium (Mg2+) represents biologically active form of total plasmatic magnesium and an essential electrolyte with an impact on cellular functions, metabolism, creation of energy substrates (ATP), myocardial electrical stability and the neuromuscular transmission. Critically ill patients face significant changes in acid-base regulation, distribution of body fluids and hormonal regulations, which render traditional estimates of total magnesium levels insufficiently informative and potentially misleading. This collaborative intersocietal position statement summarizes current state-of-the-art scientific and clinical experiences, resulting in recommendations for introduction of a routine Mg2+ measurement in the critical care practice. An availability of Mg2+ measurement in selected groups of patients is desirable in relation to new methods in the intensive care practice and is considerably supported by the known deficit of magnesium in the general population. The Mg2+ estimates are suitable for the intensive care units and the critically ill in Czechia. The prominent indications are especially regional citrate anticoagulation and renal failure, in patients with heart failure and a risk of arrhythmias including perioperative arrhythmias at the complex cardiovascular centres. Furthermore, the measurements are recommended in diabetic and septic patients. Mg2+ should be taken everywhere in shock accompanied with significant shifts in body fluids and acid-base regulation associating with a positive balance of fluids followed by a de-resuscitation phase and a subsequent fluid elimination. The measurement should be available 24/7 as part of the point-of-care analysis similarly as the level of ionised calcium (Ca2+).

Keywords: magnesium, ionised magnesium, intensive care, regional citrate anticoagulation, arrhythmias, heart failure.

Received: January 30, 2026; Revised: January 30, 2026; Accepted: February 4, 2026; Prepublished online: March 9, 2026; Published: April 9, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Balík M, Duška F, Černý V, Šrámek V, Matějovič M, Springer D, Lahoda Brodská H. Monitoring of ionized magnesium and its importance for the critically ill. Anest. intenziv. Med. 2026;37(1):50-53. doi: 10.36290/aim.2026.004.
Download citation

References

  1. Huijgen HJ, Soesan M, Sanders R, Mairuhu WM, Kesecioglu J, Sanders GT. Magnesium levels in critically ill patients. What should we measure? Am J Clin Pathol. 2000;114(5):688-95. Go to original source... Go to PubMed...
  2. Ismail Y, Ismail AA, Ismail AA. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for "normal" results. Clin Chem Lab Med. 2010;48(3):323-7. Go to original source... Go to PubMed...
  3. Curiel-García JA, Rodríguez-Morán M, Guerrero-Romero F. Hypomagnesemia and mortality in patients with type 2 diabetes. Magnes Res. 2008;21(3):163-6.
  4. Escuela MP, Guerra M, Anon JM, Martinez-Vizcaino V, Zapatero MD, Garcia-Jalon A, et al. Total and ionized serum magnesium in critically ill patients. Intensive Care Med. 2005;31(1):151-6. Go to original source... Go to PubMed...
  5. Hébert P, Mehta N, Wang J, Hindmarsh T, Jones G, Cardinal P. Functional magnesium deficiency in critically ill patients identified using a magnesium-loading test. Crit Care Med. 1997;25(5):749-55. Go to original source... Go to PubMed...
  6. Fairley J, Glassford NJ, Zhang L, Bellomo R. Magnesium status and magnesium therapy in critically ill patients: A systematic review. J Crit Care. 2015;30(6):1349-58. Go to original source... Go to PubMed...
  7. João Matias P, Azevedo A, Laranjinha I, Navarro D, Mendes M, Ferreira C, et al. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients. Blood Purif. 2014;38(3-4):244-52. Go to original source... Go to PubMed...
  8. Noormandi A, Khalili H, Mohammadi M, Abdollahi A. Effect of magnesium supplementation on lactate clearance in critically ill patients with severe sepsis: a randomized clinical trial. Eur J Clin Pharmacol. 2020;76(2):175-84. Go to original source... Go to PubMed...
  9. Kielstein JT, David S. Magnesium: the 'earth cure' of AKI? Nephrol Dial Transplant. 2013;28(4):785-7. Go to original source... Go to PubMed...
  10. Santos MS, Seguro AC, Andrade L. Hypomagnesemia is a risk factor for nonrecovery of renal function and mortality in AIDS patients with acute kidney injury. Braz J Med Biol Res. 2010;43(3):316-23. Go to original source... Go to PubMed...
  11. Matias PJ, Ávila G, Domingos D, Gil C, Ferreira A. Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients. Clin Kidney J. 2025;18(1):sfae381. Go to original source... Go to PubMed...
  12. Alves SC, Tomasi CD, Constantino L, Giombelli V, Candal R, Bristot Mde L, et al. Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury. Nephrol Dial Transplant. 2013;28(4):910-6. Go to original source... Go to PubMed...
  13. Scarpati G, Baldassarre D, Oliva F, Pascale G, Piazza O. Ionized or Total Magnesium levels, what should we measure in critical ill patients? Transl Med UniSa. 2020;23:68-76. Go to original source... Go to PubMed...
  14. Soliman HM, Mercan D, Lobo SS, Melot C, Vincent JL. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med. 2003;31(4):1082-7. Go to original source... Go to PubMed...
  15. Hutten TJA, Sikma MA, Stokwielder RH, Wesseling M, Hoefer IE, Tiel Groenestege WM. Ionized and not total magnesium as a discriminating biomarker for hypomagnesaemia in continuous venovenous haemofiltration patients. Nephrol Dial Transplant. 2021;36(4):742-3. Go to original source... Go to PubMed...
  16. Peres IT, Hamacher S, Oliveira FLC, Thomé AMT, Bozza FA. What factors predict length of stay in the intensive care unit? Systematic review and meta-analysis. J Crit Care. 2020;60:183-94. Go to original source... Go to PubMed...
  17. Tohme J, Sleilaty G, Jabbour K, Gergess A, Hayek G, Jebara V, et al. Preoperative oral magnesium loading to prevent postoperative atrial fibrillation following coronary surgery: a prospective randomized controlled trial. Eur J Cardiothorac Surg. 2022;62(5). Go to original source... Go to PubMed...
  18. Osawa EA, Cutuli SL, Cioccari L, Bitker L, Peck L, Young H, et al. Continuous Magnesium Infusion to Prevent Atrial Fibrillation After Cardiac Surgery: A Sequential Matched Case-Controlled Pilot Study. J Cardiothorac Vasc Anesth. 2020;34(11):2940-7. Go to original source... Go to PubMed...
  19. Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, et al. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med. 2009;37(6):2018-24. Go to original source... Go to PubMed...
  20. Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med. 2012;38(1):20-8. Go to original source... Go to PubMed...
  21. Zakharchenko M, Leden P, Rulíšek J, Los F, Brodska H, Balik M. Ionized Magnesium and Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy. Blood Purif. 2016;41(1-3):41-7. Go to original source... Go to PubMed...
  22. Balik M, Zakharchenko M, Leden P, Otahal M, Rulisek J, Brodska H, et al. The effects of a novel calcium-free lactate buffered dialysis and substitution fluid for regional citrate anticoagulation-prospective feasibility study. Blood Purif. 2014;38(3-4):263-72. Go to original source... Go to PubMed...
  23. Boer W, Fivez T, Vander Laenen M, Bruckers L, Grön HJ, Schetz M, et al. Citrate dose for continuous hemofiltration: effect on calcium and magnesium balance, parathormone and vitamin D status, a randomized controlled trial. BMC Nephrol. 2021;22(1):409. Go to original source... Go to PubMed...
  24. Zakharchenko M, Los F, Brodska H, Balik M. The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill. PLoS One. 2016;11(7):e0158179. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.